Manja Friese‐Hamim
- Hepatology top 5%
- Liver physiology and pathology 12
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Oncology top 10%
- Peptidase Inhibition and Analysis 12
- Lung Cancer Research Studies 5
-
- Lung Cancer Treatments and Mutations 11
-
- Ubiquitin and proteasome pathways 11
-
- Multiple Myeloma Research and Treatments 7
-
- Neuropeptides and Animal Physiology 4
- Co-authors
- Friedhelm BladtAndree BlaukatOliver SchadtClaudia WilmFrank StieberDieter DorschMichael MeyringUlrich Pehl
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Manja Friese‐Hamim
36 papers receiving 616 citations
Peers
Comparison fields: 5 of 65
- Hepatology 188
- Oncology 262
- Pulmonary and Respiratory Medicine 201
- Immunology and Allergy 35
- Pathology and Forensic Medicine 82
Countries citing papers authored by Manja Friese‐Hamim
This map shows the geographic impact of Manja Friese‐Hamim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manja Friese‐Hamim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manja Friese‐Hamim more than expected).
Fields of papers citing papers by Manja Friese‐Hamim
This network shows the impact of papers produced by Manja Friese‐Hamim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manja Friese‐Hamim. The network helps show where Manja Friese‐Hamim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Manja Friese‐Hamim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 30 | |
| 9 | 2021 | 27 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 14 | |
| 12 | 2020 | 6 | |
| 13 | 2019 | 67 | |
| 14 | 2019 | 11 | |
| 15 | 2019 | 24 | |
| 16 | 2016 | 18 | |
| 17 | 2015 | 68 | |
| 18 | 2014 | 13 | |
| 19 | 2013 | 114 | |
| 20 | 2005 | 35 |
About Manja Friese‐Hamim
Manja Friese‐Hamim is a scholar working on Hepatology, Oncology and Hematology, having authored 37 papers that have together received 626 indexed citations. Recurring topics across this work include Liver physiology and pathology (12 papers), Peptidase Inhibition and Analysis (12 papers), Ubiquitin and proteasome pathways (11 papers), Lung Cancer Treatments and Mutations (11 papers), Multiple Myeloma Research and Treatments (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Lung Cancer Research Studies (5 papers) and Neuropeptides and Animal Physiology (4 papers). The work is most often cited by research in Hepatology (188 citations), Oncology (262 citations) and Pulmonary and Respiratory Medicine (201 citations). Manja Friese‐Hamim has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Friedhelm Bladt, Andree Blaukat, Oliver Schadt, Claudia Wilm, Frank Stieber, Dieter Dorsch, Michael Meyring, Ulrich Pehl, Ulrich Grädler and Uz Stammberger. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.